These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 16389038

  • 1. Circulating angiogenic proteins in trisomy 13.
    Bdolah Y, Palomaki GE, Yaron Y, Bdolah-Abram T, Goldman M, Levine RJ, Sachs BP, Haddow JE, Karumanchi SA.
    Am J Obstet Gynecol; 2006 Jan; 194(1):239-45. PubMed ID: 16389038
    [Abstract] [Full Text] [Related]

  • 2. First trimester serum angiogenic and anti-angiogenic factors in women with chronic hypertension for the prediction of preeclampsia.
    Nzelu D, Biris D, Karampitsakos T, Nicolaides KK, Kametas NA.
    Am J Obstet Gynecol; 2020 Apr; 222(4):374.e1-374.e9. PubMed ID: 31705883
    [Abstract] [Full Text] [Related]

  • 3. In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies.
    Holme AM, Roland MC, Henriksen T, Michelsen TM.
    Am J Obstet Gynecol; 2016 Dec; 215(6):782.e1-782.e9. PubMed ID: 27503620
    [Abstract] [Full Text] [Related]

  • 4. Circulating angiogenic factors in singleton vs multiple-gestation pregnancies.
    Maynard SE, Moore Simas TA, Solitro MJ, Rajan A, Crawford S, Soderland P, Meyer BA.
    Am J Obstet Gynecol; 2008 Feb; 198(2):200.e1-7. PubMed ID: 18226624
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Changes in circulating concentrations of soluble fms-like tyrosine kinase-1 and placental growth factor measured by automated electrochemiluminescence immunoassays methods are predictors of preeclampsia.
    Leaños-Miranda A, Campos-Galicia I, Isordia-Salas I, Rivera-Leaños R, Romero-Arauz JF, Ayala-Méndez JA, Ulloa-Aguirre A.
    J Hypertens; 2012 Nov; 30(11):2173-81. PubMed ID: 22902831
    [Abstract] [Full Text] [Related]

  • 8. High early pregnancy body mass index is associated with alterations in first- and second-trimester angiogenic biomarkers.
    Beck C, Allshouse A, Silver RM, Grobman WA, Simhan H, Haas D, Reddy UM, Blue NR.
    Am J Obstet Gynecol MFM; 2022 May; 4(3):100614. PubMed ID: 35283347
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Changes in circulating level of angiogenic factors from the first to second trimester as predictors of preeclampsia.
    Vatten LJ, Eskild A, Nilsen TI, Jeansson S, Jenum PA, Staff AC.
    Am J Obstet Gynecol; 2007 Mar; 196(3):239.e1-6. PubMed ID: 17346536
    [Abstract] [Full Text] [Related]

  • 11. Accuracy of placental growth factor alone or in combination with soluble fms-like tyrosine kinase-1 or maternal factors in detecting preeclampsia in asymptomatic women in the second and third trimesters: a systematic review and meta-analysis.
    Chaemsaithong P, Gil MM, Chaiyasit N, Cuenca-Gomez D, Plasencia W, Rolle V, Poon LC.
    Am J Obstet Gynecol; 2023 Sep; 229(3):222-247. PubMed ID: 36990308
    [Abstract] [Full Text] [Related]

  • 12. Prediction of imminent preeclampsia at 35-37 weeks gestation.
    Ciobanu A, Wright A, Panaitescu A, Syngelaki A, Wright D, Nicolaides KH.
    Am J Obstet Gynecol; 2019 Jun; 220(6):584.e1-584.e11. PubMed ID: 30738886
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia?
    Bdolah Y, Lam C, Rajakumar A, Shivalingappa V, Mutter W, Sachs BP, Lim KH, Bdolah-Abram T, Epstein FH, Karumanchi SA.
    Am J Obstet Gynecol; 2008 Apr; 198(4):428.e1-6. PubMed ID: 18191808
    [Abstract] [Full Text] [Related]

  • 15. First-trimester serum soluble fms-like tyrosine kinase-1, free vascular endothelial growth factor, placental growth factor and uterine artery Doppler in preeclampsia.
    Odibo AO, Rada CC, Cahill AG, Goetzinger KR, Tuuli MG, Odibo L, Macones GA, England SK.
    J Perinatol; 2013 Sep; 33(9):670-4. PubMed ID: 23558430
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Relationship between nulliparity and preeclampsia may be explained by altered circulating soluble fms-like tyrosine kinase 1.
    Bdolah Y, Elchalal U, Natanson-Yaron S, Yechiam H, Bdolah-Abram T, Greenfield C, Goldman-Wohl D, Milwidsky A, Rana S, Karumanchi SA, Yagel S, Hochner-Celnikier D.
    Hypertens Pregnancy; 2014 May; 33(2):250-9. PubMed ID: 24304210
    [Abstract] [Full Text] [Related]

  • 18. Circulating angiogenic factors in preeclampsia, gestational proteinuria, and preeclampsia superimposed on chronic glomerulonephritis.
    Masuyama H, Suwaki N, Nakatsukasa H, Masumoto A, Tateishi Y, Hiramatrsu Y.
    Am J Obstet Gynecol; 2006 Feb; 194(2):551-6. PubMed ID: 16458660
    [Abstract] [Full Text] [Related]

  • 19. Human chorionic gonadotropin, angiogenic factors, and preeclampsia risk: a nested case-control study.
    Asvold BO, Eskild A, Vatten LJ.
    Acta Obstet Gynecol Scand; 2014 May; 93(5):454-62. PubMed ID: 24575980
    [Abstract] [Full Text] [Related]

  • 20. Angiogenic biomarkers for prediction of early preeclampsia onset in high-risk women.
    Moore Simas TA, Crawford SL, Bathgate S, Yan J, Robidoux L, Moore M, Maynard SE.
    J Matern Fetal Neonatal Med; 2014 Jul; 27(10):1038-48. PubMed ID: 24066977
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.